Additional file 1: of Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

Table S1 Lot-to-lot stability of reagents used to run the DecisionDx-Melanoma test. (DOCX 14 kb

Additional file 2: Table S1. of Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test

Cox regression analysis for distant metastasis-free (DMFS) and overall survival (OS) in the 322-subject cohort. (DOCX 12 kb

Additional file 1: Figure S1. of Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test

Survival outcomes for stage I/II patients with molecular classification by the 31-gene expression profile test. A) Recurrence-free survival, B) distant metastasis-free survival, and C) overall survival for Class 1 and Class 2 subjects with stage I or stage II disease (n = 282). (TIFF 192 kb

Lettre à Monsieur des Alliers d'Argenville, Maître des Comptes, de l'Académie Royale des Sciences de Montpellier, au sujet d'un tableau appartenant au Roi, et dont il parle dans son ouvrage de la vie des Peintres / [Chappotin de Saint-Laurent, Michel]

Référence bibliographique : Deloynes, 122